Innoviva (INVA) FCF Margin (2011 - 2026)
Innoviva posted quarterly FCF Margin of 35.5% for Q1 2026, down 1935.0% year-on-year from 1.93% in Q1 2025, and down 72.91% on a QoQ basis from 131.07% in Q3 2025.
Innoviva (INVA) has 16 years of FCF Margin data on file, last reported at 35.5% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 1935.0% year-over-year to 35.5%; the trailing twelve-month figure through Mar 2026 stood at 71.68% (down 764.0% YoY), and the FY2025 full-year result was 47.6%, down 493.0% from the prior year.
- FCF Margin for Q1 2026 stood at 35.5%, down from 131.07% in the prior quarter.
- Across five years, FCF Margin topped out at 14830.31% in Q3 2022 and bottomed at 35.5% in Q1 2026.
- The 5-year median for FCF Margin is 159.9% (2023), against an average of 2963.87%.
- The widest annual swing landed in 2022, when FCF Margin surged 1455908 bps; it then sank 1467041 bps in 2023.
- A 5-year view of FCF Margin shows it stood at 14830.31% in 2022, then sank by 99 bps to 159.9% in 2023, then decreased by 10 bps to 144.32% in 2024, then decreased by 9 bps to 131.07% in 2025, then plunged by 73 bps to 35.5% in 2026.
- The last three FCF Margin figures came in at 35.5% (Q1 2026), 131.07% (Q3 2025), and 43.95% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 35.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.50% |
| Sep 30, 2025 | 131.07% |
| Jun 30, 2025 | 43.95% |
| Mar 31, 2025 | 54.85% |
| Sep 30, 2024 | 144.32% |
| Jun 30, 2024 | 43.76% |
| Mar 31, 2024 | 3,835.09% |
| Sep 30, 2023 | 159.90% |
| Jun 30, 2023 | 3,896.12% |
| Mar 31, 2023 | 3,222.49% |
| Sep 30, 2022 | 14,830.31% |
| Jun 30, 2022 | 4,196.60% |
| Mar 31, 2022 | 7,936.33% |
| Sep 30, 2021 | 271.23% |
| Jun 30, 2021 | 7,244.35% |
| Mar 31, 2021 | 7,889.96% |
| Dec 31, 2020 | 16,920.63% |
| Sep 30, 2020 | 84.06% |
| Jun 30, 2020 | 101.07% |
| Mar 31, 2020 | 93.38% |
| Dec 31, 2019 | 88.05% |
| Sep 30, 2019 | 87.30% |
| Jun 30, 2019 | 88.13% |
| Mar 31, 2019 | 138.91% |
| Dec 31, 2018 | 77.36% |
| Sep 30, 2018 | 97.46% |
| Jun 30, 2018 | 77.10% |
| Mar 31, 2018 | 95.29% |
| Dec 31, 2017 | 68.84% |
| Sep 30, 2017 | 89.41% |
| Jun 30, 2017 | 38.66% |
| Mar 31, 2017 | 68.56% |
| Dec 31, 2016 | 48.28% |
| Sep 30, 2016 | 59.88% |
| Jun 30, 2016 | 38.35% |
| Mar 31, 2016 | 29.99% |
| Dec 31, 2015 | 30.29% |
| Sep 30, 2015 | 19.58% |
| Jun 30, 2015 | 20.40% |
| Mar 31, 2015 | -23.52% |
| Dec 31, 2014 | -65.15% |
| Sep 30, 2014 | -2,109.21% |
| Jun 30, 2014 | -5,711.03% |
| Mar 31, 2014 | -6,699.62% |
| Dec 31, 2013 | -2,786.22% |
| Sep 30, 2013 | -10,011.33% |
| Jun 30, 2013 | -1,314.45% |
| Mar 31, 2013 | -2,448.64% |
| Dec 31, 2012 | 19.71% |
| Sep 30, 2012 | -1,967.27% |
| Jun 30, 2012 | -6,697.32% |
| Mar 31, 2012 | -33.73% |
| Dec 31, 2011 | -489.76% |
| Sep 30, 2011 | -299.98% |
| Jun 30, 2011 | -299.59% |
| Mar 31, 2011 | -430.77% |